Forte Total Assets from 2010 to 2024

FBRX Stock

USD 16.00 0.36 2.30%

Forte Biosciences Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2017-03-31

Previous Quarter

26.1 M

Current Value

17.9 M

Quarterly Volatility

28.1 M

Covid

Check Forte Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Forte Biosciences' main balance sheet or income statement drivers, such as Interest Income of 1.3 M, Depreciation And Amortization of 8.6 K or Interest Expense of 14.5 K, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 0.7. Forte financial statements analysis is a perfect complement when working with Forte Biosciences Valuation or Volatility modules.

Check out the analysis of Forte Biosciences Correlation against competitors.

For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.

Latest Forte Biosciences' Total Assets Growth Pattern

Below is the plot of the Total Assets of Forte Biosciences over the last few years. Total assets refers to the total amount of Forte Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Forte Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Forte Biosciences' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Forte Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 38.98 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Forte Total Assets Regression Statistics

	Arithmetic Mean	55,994,750
	Geometric Mean	49,693,155
	Coefficient Of Variation	40.92
	Mean Deviation	16,732,033
	Median	62,175,000
	Standard Deviation	22,910,730
	Sample Variance	524.9T
	Range	95.4M
	R-Value	(0.34)
	Mean Square Error	498.6T
	R-Squared	0.12
	Significance	0.21
	Slope	(1,759,154)
	Total Sum of Squares	7348.6T

Forte Total Assets History

	2024	43.2 M
	2023	39 M
	2022	42 M
	2021	43.3 M
	2020	61.2 M
	2019	7.7 M
	2018	103.1 M

Other Fundumenentals of Forte Biosciences

Intangibles To Total Assets

Forte Biosciences Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Long Term Debt Total	Capital Surpluse	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Debt	Net Tangible Assets	Net Invested Capital	Capital Stock	Net Working Capital	Deferred Long Term Liab
Total Assets		0.83	-0.06	-0.74	0.57	-0.38	0.83	-0.38	-0.15	0.6	1.0	0.24	0.7	0.61	-0.1	-0.24	-0.28	-0.35	-0.26	0.38
Total Stockholder Equity	0.83		-0.49	-0.53	0.24	-0.22	0.54	-0.22	0.17	0.06	0.85	0.51	0.35	0.17	-0.17	0.25	0.23	0.08	0.24	-0.01
Net Debt	-0.06	-0.49		-0.06	0.04	-0.4	0.42	-0.4	-0.79	0.6	-0.08	-0.26	0.04	0.69	0.47	-0.82	-0.83	-0.53	-0.83	0.5
Retained Earnings	-0.74	-0.53	-0.06		-0.73	0.32	-0.53	0.32	0.0	-0.57	-0.73	-0.47	-0.77	-0.49	0.34	0.21	0.24	0.05	0.24	-0.04
Accounts Payable	0.57	0.24	0.04	-0.73		0.0	0.32	0.0	0.22	0.7	0.55	0.09	0.96	0.33	-0.59	-0.35	-0.36	-0.27	-0.35	0.32
Long Term Debt	-0.38	-0.22	-0.4	0.32	0.0		-0.56	1.0	0.58	-0.38	-0.39	0.14	-0.03	-0.68	-0.62	0.58	0.55	0.57	0.54	-0.51
Short Term Investments	0.83	0.54	0.42	-0.53	0.32	-0.56		-0.56	-0.61	0.72	0.83	0.07	0.48	0.87	0.29	-0.61	-0.63	-0.6	-0.62	0.55
Long Term Debt Total	-0.38	-0.22	-0.4	0.32	0.0	1.0	-0.56		0.58	-0.38	-0.39	0.14	-0.03	-0.68	-0.62	0.58	0.55	0.57	0.54	-0.51
Capital Surpluse	-0.15	0.17	-0.79	0.0	0.22	0.58	-0.61	0.58		-0.51	-0.13	0.33	0.11	-0.78	-0.71	0.65	0.65	0.63	0.64	-0.58
Total Liab	0.6	0.06	0.6	-0.57	0.7	-0.38	0.72	-0.38	-0.51		0.57	-0.28	0.77	0.87	0.05	-0.81	-0.83	-0.75	-0.83	0.71
Total Current Assets	1.0	0.85	-0.08	-0.73	0.55	-0.39	0.83	-0.39	-0.13	0.57		0.25	0.68	0.6	-0.08	-0.23	-0.26	-0.34	-0.25	0.37
Common Stock	0.24	0.51	-0.26	-0.47	0.09	0.14	0.07	0.14	0.33	-0.28	0.25		0.07	-0.23	-0.45	0.43	0.43	0.68	0.41	-0.59
Property Plant Equipment	0.7	0.35	0.04	-0.77	0.96	-0.03	0.48	-0.03	0.11	0.77	0.68	0.07		0.44	-0.54	-0.37	-0.38	-0.35	-0.38	0.33
Current Deferred Revenue	0.61	0.17	0.69	-0.49	0.33	-0.68	0.87	-0.68	-0.78	0.87	0.6	-0.23	0.44		0.47	-0.81	-0.84	-0.74	-0.83	0.71
Short Term Debt	-0.1	-0.17	0.47	0.34	-0.59	-0.62	0.29	-0.62	-0.71	0.05	-0.08	-0.45	-0.54	0.47		-0.39	-0.41	-0.41	-0.41	0.38
Net Tangible Assets	-0.24	0.25	-0.82	0.21	-0.35	0.58	-0.61	0.58	0.65	-0.81	-0.23	0.43	-0.37	-0.81	-0.39		0.99	0.84	0.98	-0.72
Net Invested Capital	-0.28	0.23	-0.83	0.24	-0.36	0.55	-0.63	0.55	0.65	-0.83	-0.26	0.43	-0.38	-0.84	-0.41	0.99		0.81	1.0	-0.71
Capital Stock	-0.35	0.08	-0.53	0.05	-0.27	0.57	-0.6	0.57	0.63	-0.75	-0.34	0.68	-0.35	-0.74	-0.41	0.84	0.81		0.78	-0.89
Net Working Capital	-0.26	0.24	-0.83	0.24	-0.35	0.54	-0.62	0.54	0.64	-0.83	-0.25	0.41	-0.38	-0.83	-0.41	0.98	1.0	0.78		-0.68
Deferred Long Term Liab	0.38	-0.01	0.5	-0.04	0.32	-0.51	0.55	-0.51	-0.58	0.71	0.37	-0.59	0.33	0.71	0.38	-0.72	-0.71	-0.89	-0.68

Click cells to compare fundamentals

About Forte Biosciences Financial Statements

Forte Biosciences investors use historical fundamental indicators, such as Forte Biosciences' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Forte Biosciences. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	39 M	43.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC